Skip to main content
Equibles

MORGAN STANLEY

Position in EDSA — Edesa Biotech, Inc.

CIK 895421 NEW YORK, NY
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,382
+$8,116 QoQ
Shares Held
1,400
-39.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 33 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. EDSA ranks #420 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in EDSA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,382 1,400
2025-12-31 $3,266 2,300
2025-06-30 $1,185 584
2024-12-31 $23 14
2024-09-30 $124 28
2024-06-30 $119 28
2024-03-31 $117 28
2023-12-31 $127 28
2023-09-30 $126 200
2022-12-31 $2,961 1,371
2022-09-30 $1,095 1,191
2022-06-30 $1,917 1,191
2022-03-31 $3,537 1,191
2021-12-31 $8,247 1,465
2021-09-30 $1,476 200